Search research articles
Contact Us
Filters
Showing results (301-310 of 351) with videos related to
Page
of 36
Sort By:
The Journal of Clinical Investigation
|
January 16, 2019
Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus
Richard Furie, Victoria P Werth, Joseph F Merola, et al.
JAMA Dermatology
|
June 26, 2020
Creation and Validation of Classification Criteria for Discoid Lupus Erythematosus
Scott A Elman, Cara Joyce, Kara Braudis, et al.
Rheumatology and Therapy
|
August 31, 2024
Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
Philip J Mease, Joseph F Merola, Yoshiya Tanaka, et al.
Rheumatology and Therapy
|
May 10, 2025
Summary of Research: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
Philip J Mease, Joseph F Merola, Yoshiya Tanaka, et al.
Rheumatology Advances in Practice
|
November 15, 2021
Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort study
Marie Skougaard, Tanja S Jørgensen, Mia J Jensen, et al.
Dermatology and Therapy
|
January 22, 2025
Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events
Mark Lebwohl, Atul Deodhar, Sergio Schwartzman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 28, 2026
Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial
Joseph F Merola, Philip Mease, Alan Kivitz, et al.
Arthritis Research & Therapy
|
February 12, 2024
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials
Atul Deodhar, Andrew Blauvelt, Mark Lebwohl, et al.
RMD Open
|
July 15, 2026
Psoriatic arthritis and obesity: a review of clinical burden and considerations for comprehensive care
Norman Madsen, Laura C Coates, Joseph F Merola, et al.
Journal of Psoriasis and Psoriatic Arthritis
|
September 20, 2024
Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings
Carly Grant, Lourdes Perez-Chada, Rebecca H Haberman, et al.
Page
of 36
Search research articles
Search
Showing results (301-310 of 351) with videos related to
Sort By:
Page
of 36
The Journal of Clinical Investigation
|
January 16, 2019
Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus
Richard Furie, Victoria P Werth, Joseph F Merola, et al.
JAMA Dermatology
|
June 26, 2020
Creation and Validation of Classification Criteria for Discoid Lupus Erythematosus
Scott A Elman, Cara Joyce, Kara Braudis, et al.
Rheumatology and Therapy
|
August 31, 2024
Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
Philip J Mease, Joseph F Merola, Yoshiya Tanaka, et al.
Rheumatology and Therapy
|
May 10, 2025
Summary of Research: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
Philip J Mease, Joseph F Merola, Yoshiya Tanaka, et al.
Rheumatology Advances in Practice
|
November 15, 2021
Change in psoriatic arthritis outcome measures impacts SF-36 physical and mental component scores differently: an observational cohort study
Marie Skougaard, Tanja S Jørgensen, Mia J Jensen, et al.
Dermatology and Therapy
|
January 22, 2025
Long-Term Safety of Ixekizumab Treatment in Patients with Psoriasis, Psoriatic Arthritis, or Axial Spondyloarthritis: a Post Hoc Analysis of Cerebro-Cardiovascular Events
Mark Lebwohl, Atul Deodhar, Sergio Schwartzman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
March 28, 2026
Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial
Joseph F Merola, Philip Mease, Alan Kivitz, et al.
Arthritis Research & Therapy
|
February 12, 2024
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials
Atul Deodhar, Andrew Blauvelt, Mark Lebwohl, et al.
RMD Open
|
July 15, 2026
Psoriatic arthritis and obesity: a review of clinical burden and considerations for comprehensive care
Norman Madsen, Laura C Coates, Joseph F Merola, et al.
Journal of Psoriasis and Psoriatic Arthritis
|
September 20, 2024
Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2021 Annual Meeting Proceedings
Carly Grant, Lourdes Perez-Chada, Rebecca H Haberman, et al.
Page
of 36